Welcome to LookChem.com Sign In|Join Free

CAS

  • or
ETHYL 2-(3-FORMYL-4-ISOBUTOXYPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLATE is an organic compound that is identified as an impurity in Febuxostat (F229000). Febuxostat is a medication that functions as a xanthine oxidase/xanthine dehydrogenase inhibitor, which is utilized in the treatment of hyperuricemia and chronic gout.

161798-03-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate Manufacturer/High quality/Best price/In stock

    Cas No: 161798-03-4

  • USD $ 3.0-3.0 / Kilogram

  • 1 Kilogram

  • 1-100 Metric Ton/Month

  • Dayang Chem (Hangzhou) Co.,Ltd.
  • Contact Supplier
  • High quality Ethyl 2-(3-Formyl-4-Iso Butoxyphenyl)-4-Methylthiazole-5-Carboxylate supplier in China

    Cas No: 161798-03-4

  • No Data

  • 1 Metric Ton

  • 30 Metric Ton/Month

  • Simagchem Corporation
  • Contact Supplier
  • 161798-03-4 Structure
  • Basic information

    1. Product Name: ETHYL 2-(3-FORMYL-4-ISOBUTOXYPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLATE
    2. Synonyms: 2-(3-forMyl;5-Thiazolecarboxylicacid, 2-[3-forMyl-4-(2-Methylpropoxy)phenyl]-4-Methyl-, ethyl ester;ethyl-2-[3-forMyl-4-(2-Methylpropoxy)phenyl]-4-Methyl-5-thiazolecarboxylate;Febuxostat Impurity 2;Febuxostat Impurity G;2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate;Ethyl 2-(3-formyl-4-isobutoxyphenyl);ETHYL 2-(3-FORMYL-4-ISOBUTOXYPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLATE
    3. CAS NO:161798-03-4
    4. Molecular Formula: C18H21NO4S
    5. Molecular Weight: 347.43
    6. EINECS: 1592732-453-0
    7. Product Categories: Febuxostat intermediate
    8. Mol File: 161798-03-4.mol
    9. Article Data: 19
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 495.9 °C at 760 mmHg
    3. Flash Point: 253.7 °C
    4. Appearance: /
    5. Density: 1.183
    6. Vapor Pressure: 5.68E-10mmHg at 25°C
    7. Refractive Index: 1.566
    8. Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
    9. Solubility: Chloroform (Slightly), Methanol (Slightly, Sonicated)
    10. PKA: 1.39±0.10(Predicted)
    11. CAS DataBase Reference: ETHYL 2-(3-FORMYL-4-ISOBUTOXYPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLATE(CAS DataBase Reference)
    12. NIST Chemistry Reference: ETHYL 2-(3-FORMYL-4-ISOBUTOXYPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLATE(161798-03-4)
    13. EPA Substance Registry System: ETHYL 2-(3-FORMYL-4-ISOBUTOXYPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLATE(161798-03-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 161798-03-4(Hazardous Substances Data)

161798-03-4 Usage

Uses

Used in Pharmaceutical Industry:
ETHYL 2-(3-FORMYL-4-ISOBUTOXYPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLATE is used as an impurity in the production of Febuxostat, a medication for the treatment of hyperuricemia and chronic gout. Its presence in the drug formulation is significant as it can impact the efficacy and safety profile of the medication. The management and control of this impurity are crucial to ensure the therapeutic benefits and minimize potential side effects of Febuxostat.

Synthesis

Preparation of Compound of formula III)[0094] A compound of formula II (10.0 gr, 34.33 mmol) was reacted with iso- butyl bromide (18.9 gr, 137.3 mmol) in the presence of potassium carbonate (19.0 gr, 137.3 mmol) and potassium iodide (2.3 gr, 13.7 mmol) in 60 ml dimethylformamide. The reaction was performed at about 70°C during 4 hours. The reaction mixture was extracted at 70°C using 300 ml ethyl acetate and 600 ml water. The separated aqueous phase was washed twice with 100 ml ethyl acetate. The combined organic phase was washed twice with 100 ml water and then concentrated to dryness. The resulting solid residue was re- crystallized from 70 ml ethyl acetate, filtered and dried under reduced pressure at about 40°C to provide a compound of formula III (8.9 gr, yield - 83percent). The Compound of formula III purity is 99.1percent (by HPLC).

Check Digit Verification of cas no

The CAS Registry Mumber 161798-03-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,1,7,9 and 8 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 161798-03:
(8*1)+(7*6)+(6*1)+(5*7)+(4*9)+(3*8)+(2*0)+(1*3)=154
154 % 10 = 4
So 161798-03-4 is a valid CAS Registry Number.
InChI:InChI=1/C18H21NO4S/c1-5-22-18(21)16-12(4)19-17(24-16)13-6-7-15(14(8-13)9-20)23-10-11(2)3/h6-9,11H,5,10H2,1-4H3

161798-03-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

1.2 Other means of identification

Product number -
Other names ethyl 2-[3-formyl-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:161798-03-4 SDS

161798-03-4Synthetic route

3-formyl-4-isobutoxythiobenzamide

3-formyl-4-isobutoxythiobenzamide

ethyl 2-chloro-3-oxo-butyrate
609-15-4

ethyl 2-chloro-3-oxo-butyrate

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 60℃; for 4h;97%
Isobutyl bromide
78-77-3

Isobutyl bromide

ethyl 2‐(3‐formyl‐4‐hydroxyphenyl)‐4‐methylthiazole‐5‐carboxylate
161798-01-2

ethyl 2‐(3‐formyl‐4‐hydroxyphenyl)‐4‐methylthiazole‐5‐carboxylate

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In N,N-dimethyl-formamide at 75 - 85℃; for 6h;94.7%
With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 8h;90%
With potassium carbonate; potassium iodide In N,N-dimethyl-formamide90%
ethyl 2‐(3‐formyl‐4‐hydroxyphenyl)‐4‐methylthiazole‐5‐carboxylate
161798-01-2

ethyl 2‐(3‐formyl‐4‐hydroxyphenyl)‐4‐methylthiazole‐5‐carboxylate

isobutyl p-toluenesulfonate
4873-56-7

isobutyl p-toluenesulfonate

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 100 - 110℃; Temperature;92.7%
isobutyl methanesulfonate
16156-53-9

isobutyl methanesulfonate

ethyl 2‐(3‐formyl‐4‐hydroxyphenyl)‐4‐methylthiazole‐5‐carboxylate
161798-01-2

ethyl 2‐(3‐formyl‐4‐hydroxyphenyl)‐4‐methylthiazole‐5‐carboxylate

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 95 - 100℃; Temperature;85.5%
ethyl 2‐(3‐formyl‐4‐hydroxyphenyl)‐4‐methylthiazole‐5‐carboxylate
161798-01-2

ethyl 2‐(3‐formyl‐4‐hydroxyphenyl)‐4‐methylthiazole‐5‐carboxylate

isobutyl benzenesulfonate
24698-43-9

isobutyl benzenesulfonate

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 95 - 100℃;84.4%
(2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester)
161797-99-5

(2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester)

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: trifluoroacetic acid / 40 h / Reflux
2: potassium carbonate; N,N-dimethyl-formamide / 4 h / 87 - 93 °C
View Scheme
Multi-step reaction with 2 steps
1.1: trifluoroacetic acid / 24 h / 80 °C
1.2: 0.17 h
2.1: potassium carbonate; potassium iodide / N,N-dimethyl-formamide / 5.08 h / 25 - 85 °C
View Scheme
Multi-step reaction with 2 steps
1: magnesium chloride; triethylamine / tetrahydrofuran / 0.17 h / Microwave irradiation
2: potassium carbonate / acetonitrile / 0.17 h / Microwave irradiation
View Scheme
ethyl 2-chloro-3-oxo-butyrate
609-15-4

ethyl 2-chloro-3-oxo-butyrate

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: isopropyl alcohol / 25 - 85 °C
2.1: trifluoroacetic acid / 24 h / 80 °C
2.2: 0.17 h
3.1: potassium carbonate; potassium iodide / N,N-dimethyl-formamide / 5.08 h / 25 - 85 °C
View Scheme
4-hydroxythiobenzamide
25984-63-8

4-hydroxythiobenzamide

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: isopropyl alcohol / 25 - 85 °C
2.1: trifluoroacetic acid / 24 h / 80 °C
2.2: 0.17 h
3.1: potassium carbonate; potassium iodide / N,N-dimethyl-formamide / 5.08 h / 25 - 85 °C
View Scheme
Multi-step reaction with 3 steps
1: phosphoric acid / water; ethanol / 30 - 80 °C
2: sulfuric acid / 60 - 120 °C
3: potassium carbonate / N,N-dimethyl-formamide / 60 - 115 °C
View Scheme
Multi-step reaction with 3 steps
1: PPA / 0.25 h / Microwave irradiation
2: magnesium chloride; triethylamine / tetrahydrofuran / 0.17 h / Microwave irradiation
3: potassium carbonate / acetonitrile / 0.17 h / Microwave irradiation
View Scheme
Multi-step reaction with 3 steps
1: ethanol / 2 h / Reflux
2: water; trifluoroacetic acid; acetic acid / 2.5 h / 100 °C
3: potassium carbonate; potassium iodide / N,N-dimethyl-formamide
View Scheme
C12H15NO2

C12H15NO2

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: tetrabutylammomium bromide; sodium hypochlorite / ethyl acetate; water / 0 - 5 °C
2: sodium hydrogen sulfide; magnesium(II) chloride hexahydrate / N,N-dimethyl-formamide / 4 h / 80 °C
3: N,N-dimethyl-formamide / 4 h / 60 °C
View Scheme
C12H13NO2

C12H13NO2

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium hydrogen sulfide; magnesium(II) chloride hexahydrate / N,N-dimethyl-formamide / 4 h / 80 °C
2: N,N-dimethyl-formamide / 4 h / 60 °C
View Scheme
4-cyanophenol
767-00-0

4-cyanophenol

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: potassium carbonate; potassium iodide / N,N-dimethyl-formamide / 6 h / 80 °C
2: aluminum (III) chloride / nitromethane / 5.5 h / 0 - 5 °C
3: iron(III) sulfate; water / toluene / 0.7 h / 110 °C
4: tetrabutylammomium bromide; sodium hypochlorite / ethyl acetate; water / 0 - 5 °C
5: sodium hydrogen sulfide; magnesium(II) chloride hexahydrate / N,N-dimethyl-formamide / 4 h / 80 °C
6: N,N-dimethyl-formamide / 4 h / 60 °C
View Scheme
Multi-step reaction with 6 steps
1: potassium carbonate; potassium iodide / N,N-dimethyl-formamide / 6 h / 80 °C
2: aluminum (III) chloride / nitromethane / 5.5 h / 0 °C
3: iron(III) sulfate; water / toluene / 0.7 h / 110 °C
4: tetrabutylammomium bromide; sodium hypochlorite / ethyl acetate; water / 0 - 5 °C
5: sodium hydrogen sulfide; magnesium(II) chloride hexahydrate / N,N-dimethyl-formamide / 4 h / 80 °C
6: N,N-dimethyl-formamide / 4 h / 60 °C
View Scheme
Multi-step reaction with 4 steps
1: polyphosphoric acid / water / 40 - 80 °C
2: phosphoric acid / water; ethanol / 30 - 80 °C
3: sulfuric acid / 60 - 120 °C
4: potassium carbonate / N,N-dimethyl-formamide / 60 - 115 °C
View Scheme
Multi-step reaction with 4 steps
1: sodium hydrogensulfide; magnesium chloride monohydrate / 3 h / 20 °C
2: PPA / 0.25 h / Microwave irradiation
3: magnesium chloride; triethylamine / tetrahydrofuran / 0.17 h / Microwave irradiation
4: potassium carbonate / acetonitrile / 0.17 h / Microwave irradiation
View Scheme
4-(2-methylpropoxy)benzonitrile
5203-15-6

4-(2-methylpropoxy)benzonitrile

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: aluminum (III) chloride / nitromethane / 5.5 h / 0 - 5 °C
2: iron(III) sulfate; water / toluene / 0.7 h / 110 °C
3: tetrabutylammomium bromide; sodium hypochlorite / ethyl acetate; water / 0 - 5 °C
4: sodium hydrogen sulfide; magnesium(II) chloride hexahydrate / N,N-dimethyl-formamide / 4 h / 80 °C
5: N,N-dimethyl-formamide / 4 h / 60 °C
View Scheme
Multi-step reaction with 5 steps
1: aluminum (III) chloride / nitromethane / 5.5 h / 0 °C
2: iron(III) sulfate; water / toluene / 0.7 h / 110 °C
3: tetrabutylammomium bromide; sodium hypochlorite / ethyl acetate; water / 0 - 5 °C
4: sodium hydrogen sulfide; magnesium(II) chloride hexahydrate / N,N-dimethyl-formamide / 4 h / 80 °C
5: N,N-dimethyl-formamide / 4 h / 60 °C
View Scheme
3-chloromethyl-4-isobutoxybenzonitrile

3-chloromethyl-4-isobutoxybenzonitrile

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: iron(III) sulfate; water / toluene / 0.7 h / 110 °C
2: tetrabutylammomium bromide; sodium hypochlorite / ethyl acetate; water / 0 - 5 °C
3: sodium hydrogen sulfide; magnesium(II) chloride hexahydrate / N,N-dimethyl-formamide / 4 h / 80 °C
4: N,N-dimethyl-formamide / 4 h / 60 °C
View Scheme
2-(4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylic acid ethyl ester hydrochloride

2-(4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylic acid ethyl ester hydrochloride

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: phosphoric acid / 70 - 95 °C
2: potassium carbonate / N,N-dimethyl-formamide / 100 - 110 °C
View Scheme
Multi-step reaction with 2 steps
1: phosphoric acid / 70 - 95 °C
2: potassium carbonate / N,N-dimethyl-formamide / 95 - 100 °C
View Scheme
Multi-step reaction with 2 steps
1: phosphoric acid / 70 - 95 °C
2: potassium carbonate / N,N-dimethyl-formamide / 95 - 100 °C
View Scheme
ethyl bromide
74-96-4

ethyl bromide

2-[3-formyl-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid
144060-62-8

2-[3-formyl-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

Conditions
ConditionsYield
With caesium carbonate In N,N-dimethyl-formamide at 60℃; for 20h;
ethyl 2-bromoacetoacetate
84911-18-2, 609-13-2

ethyl 2-bromoacetoacetate

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: ethanol / 2 h / Reflux
2: water; trifluoroacetic acid; acetic acid / 2.5 h / 100 °C
3: potassium carbonate; potassium iodide / N,N-dimethyl-formamide
View Scheme
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

2-(3-cyano-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
160844-75-7

2-(3-cyano-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

Conditions
ConditionsYield
With ammonium hydroxide; sodium persulfate; sodium iodide; iron(II) chloride In 1,2-dichloro-ethane at 20 - 50℃; for 16h; Reagent/catalyst; Solvent; Temperature;98%
With hydroxylamine hydrochloride; sodium formate In formic acid for 3h; Product distribution / selectivity; Reflux;96%
With formic acid; hydroxylamine hydrochloride; sodium formate at 100℃; for 7h;95.2%
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

aniline
62-53-3

aniline

phosphonic acid diethyl ester
762-04-9

phosphonic acid diethyl ester

ethyl 2-(3-((diethoxyphosphoryl)(phenylamino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

ethyl 2-(3-((diethoxyphosphoryl)(phenylamino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

Conditions
ConditionsYield
With β-cyclodextrin supported sulfonic acid In neat (no solvent) at 50℃; for 0.5h; Catalytic behavior; Reagent/catalyst; Solvent; Temperature; Kabachnik-Fields Reaction; Green chemistry;96%
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

4-methoxy-aniline
104-94-9

4-methoxy-aniline

phosphonic acid diethyl ester
762-04-9

phosphonic acid diethyl ester

ethyl 2-(3-((diethoxyphosphoryl)((4-methoxyphenyl)amino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

ethyl 2-(3-((diethoxyphosphoryl)((4-methoxyphenyl)amino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

Conditions
ConditionsYield
With β-cyclodextrin supported sulfonic acid In neat (no solvent) at 50℃; for 0.5h; Kabachnik-Fields Reaction; Green chemistry;96%
4-aminophenyl phenyl sulfide
1135-14-4

4-aminophenyl phenyl sulfide

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

phosphonic acid diethyl ester
762-04-9

phosphonic acid diethyl ester

ethyl 2-(3-((diethoxyphosphoryl)((4-(phenylthio)phenyl)amino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

ethyl 2-(3-((diethoxyphosphoryl)((4-(phenylthio)phenyl)amino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

Conditions
ConditionsYield
With β-cyclodextrin supported sulfonic acid In neat (no solvent) at 50℃; for 0.5h; Kabachnik-Fields Reaction; Green chemistry;96%
4-trifluoromethylphenylamine
455-14-1

4-trifluoromethylphenylamine

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

phosphonic acid diethyl ester
762-04-9

phosphonic acid diethyl ester

ethyl 2-(3-((diethoxyphosphoryl)((4-(trifluoromethyl)phenyl)amino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

ethyl 2-(3-((diethoxyphosphoryl)((4-(trifluoromethyl)phenyl)amino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

Conditions
ConditionsYield
With β-cyclodextrin supported sulfonic acid In neat (no solvent) at 50℃; for 0.5h; Kabachnik-Fields Reaction; Green chemistry;95%
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

phosphonic acid diethyl ester
762-04-9

phosphonic acid diethyl ester

4-fluoroaniline
371-40-4

4-fluoroaniline

ethyl 2-(3-((diethoxyphosphoryl)((4-fluorophenyl)amino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

ethyl 2-(3-((diethoxyphosphoryl)((4-fluorophenyl)amino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

Conditions
ConditionsYield
With β-cyclodextrin supported sulfonic acid In neat (no solvent) at 50℃; for 0.5h; Kabachnik-Fields Reaction; Green chemistry;94%
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

phosphonic acid diethyl ester
762-04-9

phosphonic acid diethyl ester

2-iodo-4-(trifluoromethyl)aniline
163444-17-5

2-iodo-4-(trifluoromethyl)aniline

ethyl 2-(3-((diethoxyphosphoryl)((2-iodo-4-(trifluoromethyl)phenyl)amino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

ethyl 2-(3-((diethoxyphosphoryl)((2-iodo-4-(trifluoromethyl)phenyl)amino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

Conditions
ConditionsYield
With β-cyclodextrin supported sulfonic acid In neat (no solvent) at 50℃; for 0.5h; Kabachnik-Fields Reaction; Green chemistry;94%
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

phosphonic acid diethyl ester
762-04-9

phosphonic acid diethyl ester

3-chloro-aniline
108-42-9

3-chloro-aniline

ethyl 2-(3-(((3-chlorophenyl)amino)(diethoxyphosphoryl)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

ethyl 2-(3-(((3-chlorophenyl)amino)(diethoxyphosphoryl)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

Conditions
ConditionsYield
With β-cyclodextrin supported sulfonic acid In neat (no solvent) at 50℃; for 0.5h; Kabachnik-Fields Reaction; Green chemistry;92%
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

4-nitro-aniline
100-01-6

4-nitro-aniline

phosphonic acid diethyl ester
762-04-9

phosphonic acid diethyl ester

ethyl 2-(3-((diethoxyphosphoryl)((4-nitrophenyl)amino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

ethyl 2-(3-((diethoxyphosphoryl)((4-nitrophenyl)amino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

Conditions
ConditionsYield
With β-cyclodextrin supported sulfonic acid In neat (no solvent) at 50℃; for 0.5h; Kabachnik-Fields Reaction; Green chemistry;92%
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

2-iodophenylamine
615-43-0

2-iodophenylamine

phosphonic acid diethyl ester
762-04-9

phosphonic acid diethyl ester

ethyl 2-(3-((diethoxyphosphoryl)((2-iodophenyl)amino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

ethyl 2-(3-((diethoxyphosphoryl)((2-iodophenyl)amino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

Conditions
ConditionsYield
With β-cyclodextrin supported sulfonic acid In neat (no solvent) at 50℃; for 0.5h; Kabachnik-Fields Reaction; Green chemistry;91%
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

thiosemicarbazide
79-19-6

thiosemicarbazide

para-bromophenacyl bromide
99-73-0

para-bromophenacyl bromide

ethyl 2-(3-((2-(4-(4-bromophenyl)thiazol-2-yl)hydrazono)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

ethyl 2-(3-((2-(4-(4-bromophenyl)thiazol-2-yl)hydrazono)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

Conditions
ConditionsYield
With acetic acid In ethanol for 3h; Reflux; Green chemistry;90%
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

phosphonic acid diethyl ester
762-04-9

phosphonic acid diethyl ester

4-bromo-aniline
106-40-1

4-bromo-aniline

ethyl 2-(3-(((4-bromophenyl)amino)(diethoxyphosphoryl)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

ethyl 2-(3-(((4-bromophenyl)amino)(diethoxyphosphoryl)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

Conditions
ConditionsYield
With β-cyclodextrin supported sulfonic acid In neat (no solvent) at 50℃; for 0.5h; Kabachnik-Fields Reaction; Green chemistry;90%
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

thiosemicarbazide
79-19-6

thiosemicarbazide

4-chlorobenzoylmethyl bromide
536-38-9

4-chlorobenzoylmethyl bromide

ethyl 2-(3-((2-(4-(4-chlorophenyl)thiazol-2-yl)hydrazono)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

ethyl 2-(3-((2-(4-(4-chlorophenyl)thiazol-2-yl)hydrazono)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate

Conditions
ConditionsYield
With acetic acid In ethanol for 4h; Reflux; Green chemistry;88%
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

thiosemicarbazide
79-19-6

thiosemicarbazide

α-bromoacetophenone
70-11-1

α-bromoacetophenone

ethyl 2-(4-isobutoxy-3-((2-(4-phenylthiazol-2-yl)hydrazono)methyl)phenyl)-4-methylthiazole-5-carboxylate

ethyl 2-(4-isobutoxy-3-((2-(4-phenylthiazol-2-yl)hydrazono)methyl)phenyl)-4-methylthiazole-5-carboxylate

Conditions
ConditionsYield
With acetic acid In ethanol for 3h; Reflux; Green chemistry;86%
3-bromoacetylcoumarin
29310-88-1

3-bromoacetylcoumarin

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

thiosemicarbazide
79-19-6

thiosemicarbazide

ethyl 2-(4-isobutoxy-3-((2-(4-(2-oxo-2H-chromen-3-yl)thiazol-2-yl)hydrazono)methyl)phenyl)-4-methylthiazole-5-carboxylate

ethyl 2-(4-isobutoxy-3-((2-(4-(2-oxo-2H-chromen-3-yl)thiazol-2-yl)hydrazono)methyl)phenyl)-4-methylthiazole-5-carboxylate

Conditions
ConditionsYield
With acetic acid In ethanol for 4h; Reflux; Green chemistry;86%
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

2-(2-bromoacetyl)-3H-benzo[f]chromen-3-one
88735-43-7

2-(2-bromoacetyl)-3H-benzo[f]chromen-3-one

thiosemicarbazide
79-19-6

thiosemicarbazide

ethyl 2-(4-isobutoxy-3-((2-(4-(3-oxo-3H-benzo[f]chromen-2-yl)thiazol-2-yl)hydrazono)methyl)phenyl)-4-methylthiazole-5-carboxylate

ethyl 2-(4-isobutoxy-3-((2-(4-(3-oxo-3H-benzo[f]chromen-2-yl)thiazol-2-yl)hydrazono)methyl)phenyl)-4-methylthiazole-5-carboxylate

Conditions
ConditionsYield
With acetic acid In ethanol for 3h; Reflux; Green chemistry;83%
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

4-Nitrophenacyl bromide
99-81-0

4-Nitrophenacyl bromide

thiosemicarbazide
79-19-6

thiosemicarbazide

ethyl 2-(4-isobutoxy-3-((2-(4-(4-nitrophenyl)thiazol-2-yl)hydrazono)methyl)phenyl)-4-methylthiazole-5-carboxylate

ethyl 2-(4-isobutoxy-3-((2-(4-(4-nitrophenyl)thiazol-2-yl)hydrazono)methyl)phenyl)-4-methylthiazole-5-carboxylate

Conditions
ConditionsYield
With acetic acid In ethanol for 4h; Reflux; Green chemistry;81%
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

febuxostat

febuxostat

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydroxylamine hydrochloride; sodium formate; formic acid / 100 °C
2: sodium hydroxide; ethanol / tetrahydrofuran / 1 h / 60 °C
View Scheme
Multi-step reaction with 3 steps
1.1: hydroxylamine hydrochloride / methanol / 65 °C
2.1: sodium hydroxide; water / methanol / 0.5 h / 75 °C
2.2: hydrose / 5 h / 25 °C / pH 2 - 3
3.1: sodium formate; formic acid / 100 °C
View Scheme
With formic acid; hydroxylamine hydrochloride; sodium formate for 5h; Reflux;
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

2-[3-formyl-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid
144060-62-8

2-[3-formyl-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid

Conditions
ConditionsYield
Stage #1: 2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester With water; sodium hydroxide In methanol at 75℃; for 0.5h;
Stage #2: With hydrogenchloride In methanol; water at 25℃; for 5h; pH=2 - 3;
Stage #1: 2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester With sodium hydroxide In ethanol at 80℃; for 4h;
Stage #2: With hydrogenchloride In ethanol; water pH=~ 3;
Stage #1: 2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester With water; potassium carbonate In methanol for 3h; Reflux;
Stage #2: With hydrogenchloride In water at 40℃; pH=5.3 - 5.7; Product distribution / selectivity;
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

ethyl 2-[3-((hydroxyimino)methyl)-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylate
1271738-74-9

ethyl 2-[3-((hydroxyimino)methyl)-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylate

Conditions
ConditionsYield
With hydroxylamine hydrochloride In methanol at 65℃;
With formic acid; hydroxylamine hydrochloride; sodium formate at 100 - 110℃;
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

2-[3-((hydroxyimino)methyl)-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid
1350352-70-3

2-[3-((hydroxyimino)methyl)-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: hydroxylamine hydrochloride / methanol / 65 °C
2.1: sodium hydroxide; water / methanol / 0.5 h / 75 °C
2.2: hydrose / 5 h / 25 °C / pH 2 - 3
View Scheme
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid methylamine
1350352-71-4

2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid methylamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydroxylamine hydrochloride; sodium formate; formic acid / 100 °C
2: sodium hydroxide; ethanol / tetrahydrofuran / 1 h / 60 °C
3: ethyl acetate; cyclohexane; methanol / 3 h
View Scheme
Multi-step reaction with 4 steps
1.1: hydroxylamine hydrochloride / methanol / 65 °C
2.1: sodium hydroxide; water / methanol / 0.5 h / 75 °C
2.2: hydrose / 5 h / 25 °C / pH 2 - 3
3.1: sodium formate; formic acid / 100 °C
4.1: ethyl acetate; cyclohexane; methanol / 3 h
View Scheme
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid tert-butylamine
1350352-72-5

2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid tert-butylamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydroxylamine hydrochloride; sodium formate; formic acid / 100 °C
2: sodium hydroxide; ethanol / tetrahydrofuran / 1 h / 60 °C
3: toluene / 10 h
View Scheme
Multi-step reaction with 4 steps
1.1: hydroxylamine hydrochloride / methanol / 65 °C
2.1: sodium hydroxide; water / methanol / 0.5 h / 75 °C
2.2: hydrose / 5 h / 25 °C / pH 2 - 3
3.1: sodium formate; formic acid / 100 °C
4.1: toluene / 10 h
View Scheme
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

2-[3-formyl-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid methylamine
1350352-73-6

2-[3-formyl-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid methylamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: sodium hydroxide; water / methanol / 0.5 h / 75 °C
1.2: hydrose / 5 h / 25 °C / pH 2 - 3
2.1: ethyl acetate; cyclohexane; methanol / 3 h
View Scheme
2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester
161798-03-4

2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

2-[3-formyl-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid n-butylamine
1350352-74-7

2-[3-formyl-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid n-butylamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: sodium hydroxide; water / methanol / 0.5 h / 75 °C
1.2: hydrose / 5 h / 25 °C / pH 2 - 3
2.1: toluene / 10 h
View Scheme

161798-03-4Relevant articles and documents

Design, synthesis, cytotoxic evaluation and molecular docking studies of novel thiazolyl α-aminophosphonates

Gundluru, Mohan,Badavath, Vishnu Nayak,Shaik, Haroon Yasmin,Sudileti, Murali,Nemallapudi, Bakthavatchala Reddy,Gundala, Sravya,Zyryanov, Grigory V.,Cirandur, Suresh Reddy

, p. 1139 - 1160 (2020/11/16)

Abstract: A new class of thiazolyl α-aminophosphonate derivatives was synthesized by one-pot Kabachnik–Fields reaction of ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate with various aryl amines and diethyl phosphite under solvent-free conditions using β-cyclodextrin supported sulfonic acid (β-CD-SO3H) as an efficient, reusable and heterogeneous solid acid catalyst. The products were obtained in good to excellent yields at shorter reaction time. All the title compounds were screened for cytotoxic activity against human breast cancer (MCF-7 and MDA-MB-231), prostate cancer (DU-145) liver cancer (HepG2) and HeLa cancer cell lines using sulfarodamine-B (SRB assay). Compounds (8b, –4OMe), (8h, –4NO2) and (8j, –2I, –4CF3) showed better anticancer activity when compared with standard drug Adriamycin. Further in-silico target hunting reveals the anticancer activity of the designed compounds by inhibiting DNA topoisomerase II. Graphical abstract: [Figure not available: see fulltext.].

Controlled Relay Process to Access N-Centered Radicals for Catalyst-free Amidation of Aldehydes under Visible Light

Chang, Sukbok,Jeon, Hyun Ji,Jung, Hoimin,Kim, Dongwook,Lee, Wongyu,Seo, Sangwon

supporting information, p. 495 - 508 (2021/01/28)

Nitrogen-centered radicals have attracted increasing attention as a versatile reactive intermediate for diverse C–N bond constructions. Despite the significant advances achieved in this realm, the controllable formation of such species under catalyst-free conditions remains highly challenging. Here, we report a new relay process involving the slow in situ generation of a photoactive N-chloro species via C–N bond formation, which subsequently enables mild and selective access to N-centered radicals under visible light conditions. The utility of this approach is demonstrated by the conversion of aldehydes to amides, employing N-chloro-N-sodio carbamates as a practical amidating source. This synthetic operation obviates the need for catalysts, external oxidants, and coupling reagents that are typically required in related processes, consequently allowing high functional group tolerance and excellent applicability for late-stage functionalization. Amides are an important class of structural motifs prevalently found in bioactive compounds and synthetic materials of great significance. Amidation of aldehydes has been established as an atom-efficient strategy for amide synthesis; however, current methods lack in applicability mainly due to the requirement of troublesome reagents. In this article, we describe an unconventional relay process to convert aldehydes to amides under catalyst-, oxidant-, and coupling-reagent-free conditions, which is enabled by the development of a new mechanistic platform that gives efficient and controllable access to N-centered radicals under visible light. A wide range of (hetero)aromatic and aliphatic aldehydes can be employed, including those derived from biologically relevant complex molecules. We anticipate that the accomplished methodological advances, combined with the unique mechanistic features, will lead to the widespread application of the present strategy in broad research fields. A catalyst-free approach for controlled access to N-centered radicals is described, which enables the conversion of aldehydes to amides via an unconventional relay process harnessing visible light. The key tactic relies on the use of photostable N-chloro-N-sodio-carbamate amidating reagent that leads to slow incorporations of a photoactive radical source via C–N formation and other involved intermediates thereafter. This methodology displays excellent applicability and sustainable chemistry credentials and, thus, holds a promise for finding broad applications.

Synthesis, molecular docking, DFT study of novel N-benzyl-2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxamide derivatives and their antibacterial activity

Sam Daniel Prabu,Lakshmanan, Sivalingam,Thirumurugan,Ramalakshmi,Arul Antony

, p. 619 - 626 (2020/02/06)

A series of febuxostat based new chemical entities was synthesized using microwave method and characterized by NMR, mass and FT-IR spectral studies. Molecular docking of febuxostat amide nucleus substitution compounds 8c (-7.91kcal/mol), 8g (-7.94 kcal/mol) exhibiting high binding energy against ALK receptors. Theoretical investigation of MEPs, HOMO, LUMO and energy gap of HOMO-LUMO were calculated by B3LYP/6-31G method. Among the tested compounds, methoxy substituted compound 8g showed highest antibacterial activity against S. aereus and B. subtilis.

Method for synthesizing febuxostat and intermediate thereof

-

, (2020/05/02)

The invention relates to a method for synthesizing febuxostat and an intermediate thereof, specifically a method for synthesizing 2-(3-formyl-4-isobutoxy-phenyl)-4-methyl-thiazole-5-carboxylic acid ethyl ester. The method comprises the following steps: preparing 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate; enabling the product obtained in the step (a) to react in DMF (Dimethyl Formamide) in the presence of potassium carbonate and bromo-isobutane, adding water and ethyl acetate for extraction, concentrating to obtain an organic layer, and recrystallizing with DMF to obtain 2-(3-formyl-4-isobutoxy-phenyl)-4-methyl-thiazole-5-carboxylic acid ethyl ester. The invention also relates to 2-(3-formyl-4-isobutoxy-phenyl)-4-methyl-thiazole-5-carboxylic acid ethyl ester and 2-(3-formyl-4-hydroxyphenyl)-4-methyl-5-thiazoleethyl formate and application thereof to the preparation of febuxostat. The method of the invention has excellent performance.

Febuxostat and intermediates and synthesis thereof

-

, (2020/05/09)

The invention relates to febuxostat and intermediates and synthesis thereof, in particular to a method for synthesizing 2-(3-formyl-4-hydroxyphenyl)-4-methyl-5-thiazole ethyl formate, which comprisesthe following operation steps: (1) adding a reactant 2-(4-hydroxyphenyl)-4-methyl-5-thiazole ethyl formate into a mixture of polyphosphoric acid and methanesulfonic acid, and uniformly stirring the materials; (2) adding a Darf reaction reagent hexamethylenetetramine into the reaction mixture while stirring, continuously reacting, and cooling; and (3) adding saturated brine ice, separating out solid, filtering, cleaning the solid with water to-be-neutral, and drying to obtain the product. The invention also relates to 2-(3-formyl-4-hydroxyphenyl)-4-methyl-5-thiazole ethyl formate and to the usethereof for the preparation of febuxostat. The method has excellent performance.

Synthesis method of febuxostat impurity

-

Paragraph 0093-0095, (2020/07/13)

The invention provides a synthesis method of a febuxostat impurity, which is characterized in that 2-[3-formyl-4-isobutoxyphenyl]-4-methylthiazole-5-formic acid is used as a raw material, and the febuxostat impurity is prepared by a four-step synthesis method. The synthesis process provided by the invention has the advantages of mild reaction conditions, no need of special chemical reagents, highyield and purity up to 99%, and can be used as a standard substance or a reference substance for quality control of febuxostat series products.

New preparation method of febuxostat intermediate

-

Paragraph 0102-0104; 0108-0110; 0122-0124, (2020/03/06)

The invention relates to a new preparation method of a febuxostat intermediate. The method includes: taking cheap 4-hydroxybenzaldehyde as an initial raw material, firstly preparing aldoxime from 4-hydroxybenzaldehyde and hydroxylamine hydrochloride, then adding a corresponding thio reagent, and preparing a compound 4-hydroxythiobenzamide (152A1-00) by Beckmann rearrangement reaction; utilizing one-pot process, adopting cheap 4-hydroxybenzaldehyde as an initial raw material, carrying out a series of reactions, and then performing cyclization with 2-halogenated ethyl acetoacetate to obtain ethyl 2-(4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate or different salt forms (152A2x) thereof; and using isobutyl sulfonate (152H1x) with more easily controllable quality to replace bromo-isobutane soas to prepare ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate (152A4-00). In conclusion, the method provided by the invention is more beneficial to safe, simple and cost-efficientindustrial scale preparation of the febuxostat intermediate with higher purity.

Method for continuously preparing febuxostat

-

Paragraph 0009; 0014; 0017, (2020/07/06)

The invention discloses a method for continuously preparing febuxostat. The method comprises the following steps: by taking a compound represented by a formula (II) as a raw material, carrying out anetherification reaction to obtain a compound solution represented by a formula (III), filtering, carrying out reduced pressure distillation on filtrate to recover excessive bromo-iso-butane, carryingout a cyanation reaction on the residual filtrate to obtain a compound solution represented by a formula (IV), adding an alkali, and carrying out an ester hydrolysis reaction to obtain the febuxostat(I). By optimizing the preparation process of febuxostat, the whole preparation of the febuxostat can be continuously produced, the prepared febuxostat is high in yield and good in purity, the use ofa large amount of acid solvents in the traditional process is avoided, the operation steps are simple, and the preparation method is particularly suitable for industrial production.

High purity febuxostat preparation method

-

Paragraph 0006; 0028-0037, (2019/07/04)

The invention relates to febuxostat preparation method, wherein the 2 - (3 - thiophene - 4 - hydroxy-phenyl) - 4 - methyl thiazole - 5 - carboxylic acid ethyl ester with isobutyl bromide after completion of the reaction, the reaction solution after treatment as follows: 1) adding purified water, separating out the first crystal; 2) a first crystal to purified water beating, get the secondary crystal; 3) the secondary crystal to 1: 1.2 - 2.0 mass ratio of ethanol - formic acid solution recrystallization, to obtain compound (2 - (3 - formyl - 4 - isobuoxy - phenyl) - 4 - methyl - thiazole - 5 - carboxylic acid ethyl ester (FBT - 1). Through the step of optimizing the reaction post, obviously improves the key intermediate purity and yield, thereby improving the purity of the final product febuxostat and yield.

Preparation method of Febuxostat

-

Paragraph 0069-0072; 0080; 0081, (2019/02/25)

The invention provides a preparation method of Febuxostat, and belongs to the technical field of pharmaceutical synthesis. According to the method provided by the invention, with 2-(3-formyl-4-hydroxyphenyl)-4-methyl-thiazole-5-ethyl carboxylate as a raw material, the Febuxostat is synthesized through an isobutylation reaction, a cyanation reaction and a hydrolysis reaction. The synthesis route issimple; through aftertreatment of the product of each step of the reaction as well as refining for purification, crystal regulation and the like on crude products, the product purity and yield are remarkably improved, the cost is lowered, and the operation is easier and more reasonable; moreover, the preparation method provided by the invention has the advantages of mild reaction conditions and lower energy consumption and is more suitable for industrial production.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 161798-03-4